Fig. 3From: Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapyEngineered activatory receptors of NK cells strengthen NK cells in tumor killing. CAR redirect tumor cell-specific NK cells to bind to their specific target on the surface of the cancer cell, resulting in NK cell activation, cytolytic factors secretion, and tumor lysisBack to article page